The evolution of European guidelines: changing the management of cholesterol levels

Area of Science:

• Cardiology
• Public Health

Background:

• Cardiovascular disease (CVD) is a primary cause of mortality in Europe and the US.
• Lipid management is a cornerstone of CVD prevention strategies.
• Current guidelines emphasize lipid lowering but face challenges in goal attainment.

Purpose of the Study:

• To review the evolution of European lipid guidelines for CVD.
• To advocate for risk-based intensity of lipid-lowering therapy.
• To highlight the need for improved CVD risk management and treatment access.

Main Methods:

• Review of Joint European Societies' guidelines on lipid recommendations.
• Analysis of the role of global cardiovascular risk in treatment decisions.
• Discussion on the implications of near-term versus lifetime risk assessment.

Main Results:

• Guidelines increasingly focus on treating global CVD risk.
• Baseline lipid levels alone are insufficient to direct lipid-lowering therapy intensity.
• No clear cholesterol threshold exists beyond which lowering provides no benefit.

Conclusions:

• Patient global CVD risk, not just baseline lipids, should guide lipid-lowering treatment intensity.
• Lifetime cardiovascular risk assessment may be underemphasized.
• Urgent action is needed to improve goal attainment and access to risk-reducing treatments for CVD.